New technologies and potential cost savings related to morbidity and mortality reduction in Class III/IV heart failure patients in Canada
- 1 March 2003
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 88 (1) , 33-41
- https://doi.org/10.1016/s0167-5273(02)00378-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Resource Use and Survival of Patients Hospitalized with Congestive Heart Failure: Differences in Care by Specialty of the Attending PhysicianAnnals of Internal Medicine, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Ventricular assist device programs: design and function.The Annals of Thoracic Surgery, 1999
- Insights into the contemporary epidemiology and outpatient management of congestive heart failureAmerican Heart Journal, 1999
- ACE inhibitors in the management of congestive heart failure: Comparative economic dataAmerican Heart Journal, 1999
- Cost effective management programme for heart failure reduces hospitalisationHeart, 1998
- Cost Effectiveness of Artificial Organ TherapiesAsaio Journal, 1998
- Treatment of Patients Admitted to the Hospital With Congestive Heart Failure: Specialty-Related Disparities in Practice Patterns and OutcomesJournal of the American College of Cardiology, 1997
- Mortality Risk and Patterns of Practice in 4606 Acute Care Patients With Congestive Heart FailureArchives of internal medicine (1960), 1996
- The Effect of a Nurse-Managed CHF Clinic on Patient Readmission and Length of StayHome Healthcare Now, 1996